BRKS - Brooks Automation acquires Trans-Hit Biomarkers
Brooks Automation (BRKS) acquired Montreal, Canada based Trans-Hit Biomarkers ((THB)), a worldwide biospecimen procurement service provider.THB has an extensive collection capability for biospecimens and clinical samples through a worldwide partner network of clinical sites and biobanks.Dr. Pascal Puchois, the founder and CEO of THB, will continue to lead the business as part of Brooks Life Sciences.Brooks expects the acquisition to be modestly accretive to earnings immediately.Specific acquisition terms were not disclosed.
For further details see:
Brooks Automation acquires Trans-Hit Biomarkers